Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Innexus Biotechnology Inc

+ Add to Watchlist

IXSBF:US

0.0005 USD 0.00000.00%

As of 20:10:02 ET on 02/26/2015.

Trading has been halted for IXSBF:US

Snapshot for Innexus Biotechnology Inc (IXSBF)

Open: - Day's Range: - Volume: 834,392
Previous Close: 0.0005 52wk Range: 0.0001 - 0.0015 1-Yr Rtn: -

Stock Chart for IXSBF

No chart data available.
  • IXSBF:US 0.0007
  • 1D
  • 1M
  • 1Y
0.0005
Interactive IXSBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IXSBF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 37,299
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IXSBF

No data available

Company Profile & Key Executives for IXSBF

InNexus Biotechnology Inc. is developing a new generation of monoclonal antibodies termed SuperAntibodies (SAT). The Company is exploiting SAT to generate second generation diagnostic and therapeutic antibodies. InNexus is focused on marketing the SAT to the pharmaceutical community for the purpose of entering into licensing agreements.

More Company Profile & Key Executives for IXSBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil